Latest AI and machine learning research in leukemia for healthcare professionals.
Blood diseases and disorders, including leukemia and infectious diseases of red blood cells, pose significant diagnostic challenges due to their complex presentations and reliance on time-consuming cytomorphological analysis to detect subtle morphologic features. While microscopic examination remains the gold standard in their diagnosis, its dependence on expert interpretation high-lights the need...
Chronic Myeloid Leukemia (CML) progresses through chronic, accelerated, and blast crisis phases, making disease stratification and therapeutic response prediction challenging. IGF2BP3 (Insulin-like Growth Factor 2 mRNA Binding Protein 3) has emerged as a potential prognostic biomarker due to its involvement in RNA stability and oncogenic pathways. This study employed a multi-platform approach, inc...
Accelerated knee MRI protocols using deep learning (DL)-based reconstruction, 3D acquisitions, and parallel imaging can significantly reduce scan time...
We developed a classifier to infer acute ischemic stroke (AIS) severity from Medicare claims using the Modified Rankin Scale (mRS) at discharge. The c...
Pelvic pain (dysmenorrhea and non-menstrual) is the most common presentation of adolescent endometriosis, but symptoms vary between and within patient...
Four-Dimensional Computed Tomography (4DCT) shows promise in diagnosing wrist pathologies such as scapholunate ligament lesions (SLL). Two parameters ...
Distinguishing cell types in peripheral blood smears is critical for diagnosing blood diseases, such as leukemia subtypes. Artificial intelligence can...
Vaccination is a potent means to combat the spread of infectious disease epidemics or pandemics, such as the COVID-19 pandemic. However, getting suffi...
Conventional chemotherapeutics exploit cancer’s hallmark of active cell cycling, primarily targeting mitotic cells. Consequently, the mitotic index (M...
Acute Hepatic Porphyria (AHP) is a rare genetic disease characterized by unpredictable life-threatening attacks. There is no reliable biochemical scre...
Accurate understanding of biological aging and the impact of environmental stressors is crucial for understanding cardiovascular health and identifyin...
The complexity of distribution of inflammatory cells in the kidney is not well captured by conventional semiquantitative visual assessment. This study...
Functional outcomes after stroke are commonly assessed via modified Rankin Scale (mRS). However, mRS is subject to patient and assessor biases and is ...
Introduction: Achieving equity in translational precision medicine requires the integration of genomic, clinical, and social determinants of health (S...
Acute Myeloid Leukemia (AML) is a complex and heterogeneous disease identified by severe clinical progression, fast cellular proliferation, and often ...
Extracting structured data from clinical notes remains a key bottleneck in clinical research. We hypothesized that with minimal computational and anno...
Sub-Saharan Africa bears the highest burden of all Sickle Cell disease births worldwide. Chronic haemolysis in children with sickle cell disease (SCD)...
Genomic testing has transformed treatment decisions for hormone receptor-positive, HER2-negative (HR+/HER2-) early breast cancer; however, it remains ...
In glioblastoma (GBM), promoter methylation of the O6-methylguanine-DNA methyltransferase (MGMT) is associated with beneficial chemotherapy but has no...
Muscle-invasive bladder cancer (MIBC) is associated with poor predictability of response to cisplatin-based neoadjuvant chemotherapy (NAC). Consequent...